Zinger Key Points
- Emerson's net sales surged 17% YoY, surpassing estimates.
- Emerson revises FY24 net sales growth forecast to 15%-16%, adjusted EPS guidance to $5.40-$5.50.
Emerson Electric Co EMR shares are trading lower after the company reported second-quarter FY24 net sales growth of 17% Y/Y to $4.38 billion, beating the consensus of $4.29 billion.
Underlying sales were up 8% Y/Y, and underlying orders declined by 1% Y/Y in the quarter.
Sales by Segments: Final Control $1.05 billion (+6% Y/Y), Measurement & Analytical $1.01 billion (+14% Y/Y), Discrete Automation $632 million (-8% Y/Y); Safety & Productivity $365 million (+1% Y/Y), Control Systems & Software $687 million (+11% Y/Y), AspenTech $278 million (+21% Y/Y), and Test & Measurement $367 million.
Adjusted Total Segment EBITA was $1.14 billion compared to $924 million in the prior year quarter, and the margin improved by 140 bps to 26.0%.
Adjusted EPS improved 25% Y/Y to $1.36, beating the consensus of $1.25.
Emerson’s operating cash for the quarter totaled $757 million, compared to $575 million in the prior year, and free cash flow was $675 million (+32% Y/Y).
Emerson held cash and equivalents of $2.32 billion as of March-end.
Dividend: Emerson declared a quarterly cash dividend per share of $0.525, payable on June 10 to stockholders of record on May 17.
Outlook: For the third quarter, Emerson Electric expects net sales growth of 11%-12.5%, with underlying sales growth of 3%-4.5% and adjusted EPS of $1.38-$1.42 versus the consensus of $1.44.
For FY24, Emerson Electric revised its net sales growth outlook to 15% – 16% (prior: 14.5% -17%), with underlying sales growth to 5.5%-6.5% (from 4.5%-6.5% earlier) and adjusted EPS to $5.40-$5.50 (from $5.30-$5.45) vs. consensus $5.39.
Emerson expects an operating cash flow of $3.1 billion and an FCF of $2.7 billion for FY24.
Investors can gain exposure to the stock via ProShares S&P Kensho Smart Factories ETF MAKX and Gabelli Automation ETF GAST.
Price Action: EMR shares are up 1.74% at $109.27 at the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.